Journals / Journal of Health Sciences and Medicine / 2026 / Volume: 9 Issue: 6

Comparison of the cross-suture and parallel suture techniques with proglide in transfemoral TAVI: a single-center retrospective study

Şükriye Uslu(Health Science University, Antalya Training and Research Hospital, Department of Cardiology)0000-0001-7504-7637
Gülsüm Meral Yılmaz Öztekin(Health Science University, Antalya Training and Research Hospital, Department of Cardiology)0000-0001-9540-5075
Muhammed Rıdvan Ersoysal(Health Science University, Antalya Training and Research Hospital, Department of Cardiology)0000-0002-9608-3220
Görkem Kuş(Health Science University, Antalya Training and Research Hospital, Department of Cardiology)0000-0002-6058-5501
Nermin Bayar(Health Science University, Antalya Training and Research Hospital, Department of Cardiology)0000-0001-6785-3137
Şakir Arslan(Health Science University, Antalya Training and Research Hospital, Department of Cardiology)0000-0002-2907-4957
Pages
—
Publication Date
2026-10-25
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These findings should be considered hypothesis-generating and require confirmation in larger prospective studies.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aims: This study aimed to evaluate vascular complications associated with the use of the ProGlide device by comparing the cross-suture technique (CST) and the parallel suture technique (PST).
📊
Key Findings & Data:Methods: A total of 119 consecutive patients with severe symptomatic aortic stenosis who underwent transfemoral transcatheter aortic valve implantation (TF-TAVI) were included in this study.
💡
Conclusion & Impact:These findings should be considered hypothesis-generating and require confirmation in larger prospective studies.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:TAVI · ProGlide · closure device

Abstract

Aims: This study aimed to evaluate vascular complications associated with the use of the ProGlide device by comparing the cross-suture technique (CST) and the parallel suture technique (PST). Methods: A total of 119 consecutive patients with severe symptomatic aortic stenosis who underwent transfemoral transcatheter aortic valve implantation (TF-TAVI) were included in this study. CST was applied by placing the sutures at the 10 and 2 o’clock positions as described by the manufacturer, whereas PST was applied at the medial and lateral positions. Vascular complications (VCs) and bleeding complications (BCs) were classified according to the Valve Academic Research Consortium-3 (VARC-3) criteria. Results: Minor VCs were significantly more frequent in the CST group than in the PST group (p=0.001). Regardless of the degree of vascular obstruction, the incidence was significantly lower in the PST group than in the CST group (p=0.012). Conclusion: In this single-center retrospective cohort, PST was associated with fewer minor vascular complications and less angiographic vascular obstruction compared to CST. These findings should be considered hypothesis-generating and require confirmation in larger prospective studies.

🔖

Cite This Article

Uslu, Ş., Öztekin, G. M. Y., Ersoysal, M. R., Kuş, G., Bayar, N., Arslan, Ş. (2026). Comparison of the cross-suture and parallel suture techniques with proglide in transfemoral TAVI: a single-center retrospective study. Journal of Health Sciences and Medicine, Volume: 9 Issue: 6. https://ajindex.com/articles/1668041

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (25)

  1. Pascual I, Carro A, Avanzas P, et al. Vascular approaches for transcatheter aortic valve implantation. J Thorac Dis. 2017;9(Suppl 6): S478-S487. doi:10.21037/jtd.2017.05.73
  2. Sherwood MW, Xiang K, Matsouaka R, et al. Incidence, temporal trends, and associated outcomes of vascular and bleeding complications in patients undergoing transfemoral transcatheter aortic valve replacement: insights from the Society of Thoracic Surgeons/American College of Cardiology transcatheter valve therapies registry. Circ Cardiovasc Interv. 2020;13(1):e008227. doi:10.1161/CIRCINTERVENTIONS.119.008227
  3. Barbash IM, Barbanti M, Webb J, et al. Comparison of vascular closure devices for access site closure after transfemoral aortic valve implantation. Eur Heart J. 2015;36(47):3370-3379. doi:10.1093/eurheartj/ehv417
  4. Berti S, Bedogni F, Giordano A, et al. Efficacy and safety of ProGlide versus Prostar XL vascular closure devices in transcatheter aortic valve replacement: the RISPEVA registry. J Am Heart Assoc. 2020;9(21): e018042. doi:10.1161/JAHA.120.018042
  5. Seeger J, Gonska B, Rodewald C, Rottbauer W, Wohrle J. Impact of suture mediated femoral access site closure with the Prostar XL compared to the ProGlide system on outcome in transfemoral aortic valve implantation. Int J Cardiol. 2016;223:564-567. doi:10.1016/j.ijcard.2016.08.193
  6. Ott I, Shivaraju A, Schaffer NR, et al. Parallel suture technique with ProGlide: a novel method for management of vascular access during transcatheter aortic valve implantation (TAVI). EuroIntervention. 2017; 13(8):928-934. doi:10.4244/EIJ-D-16-01036
  7. Marcusohn E, Qasum M, Epstein D, et al. Vascular complications among patients undergoing trans-femoral transcatheter aortic valve implantation: Prostar vs ProGlide parallel technique. Angiology. 2022; 73(7):635-642. doi:10.1177/00033197211058498
  8. Toggweiler S, Leipsic J, Binder RK, et al. Management of vascular access in transcatheter aortic valve replacement: part 1: basic anatomy, imaging, sheaths, wires, and access routes. JACC Cardiovasc Interv. 2013;6(7):643-653. doi:10.1016/j.jcin.2013.04.003
  9. Committee VW, Généreux P, Piazza N, et al. Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research. Eur Heart J. 2021;42(19):1825-1857. doi: 10.1016/j.jacc.2021.02.038
  10. Power D, Schafer U, Guedeney P, et al. Impact of percutaneous closure device type on vascular and bleeding complications after TAVR: a post hoc analysis from the BRAVO-3 randomized trial. Catheter Cardiovasc Interv. 2019;93(7):1374-1381. doi:10.1002/ccd.28295
  11. van Wiechen MP, Tchetche D, Ooms JF, et al. Suture- or plug-based large-bore arteriotomy closure: a pilot randomized controlled trial. JACC Cardiovasc Interv. 2021;14(2):149-157. doi:10.1016/j.jcin.2020.09.052
  12. Dimitriadis Z, Scholtz W, Ensminger SM, et al. Impact of sheath diameter of different sheath types on vascular complications and mortality in transfemoral TAVI approaches using the Proglide closure device. PLoS One. 2017;12(8):e0183658. doi:10.1371/journal.pone.0183658
  13. Shoeib O, Burzotta F, Aurigemma C, et al. Percutaneous transcatheter aortic valve replacement induces femoral artery shrinkage: angiographic evidence and predictors for a new side effect. Catheter Cardiovasc Interv. 2018;91(5):938-944. doi:10.1002/ccd.27248
  14. Xiang Y, Chen C, Zhao J, Ma Y, Huang B, Wu Z. Vascular complications of ProGlide versus Prostar in transcatheter aortic valve replacement (TAVR) procedures: meta-analysis. BJS Open. 2023;7(4):zrad061. doi:10.1093/bjsopen/zrad061
  15. Tarantini G. MANTA dedicated large-bore vessel closure device. Circ Cardiovasc Interv. 2019;12(7):e008203. doi:10.1161/CIRCINTERVENTIONS.119.008203
  16. Abdel-Wahab M, Hartung P, Dumpies O, et al. Comparison of a pure plug-based versus a primary suture-based vascular closure device strategy for transfemoral transcatheter aortic valve replacement: the CHOICE-CLOSURE randomized clinical trial. Circulation. 2022;145(3): 170-183. doi:10.1161/CIRCULATIONAHA.121.057856
  17. Dumpies O, Jobs A, Obradovic D, et al. Comparison of plug-based versus suture-based vascular closure for large-bore arterial access: a collaborative meta-analysis of observational and randomized studies. Clin Res Cardiol. 2023;112(5):614-625. doi:10.1007/s00392-022-02145-5
  18. Yeh CF, Kao HL, Ko TY, et al. Dual ProGlide vs ProGlide and Angio-Seal for femoral access hemostasis after transcatheter aortic valve replacement: a randomised comparative trial. Can J Cardiol. 2025;41(1): 12-20. doi:10.1016/j.cjca.2024.09.001
  19. Rheude T, Ruge H, Altaner N, et al. Comparison of strategies for vascular ACCESS closure after transcatheter aortic valve implantation: the ACCESS-TAVI randomized trial. Eur Heart J. 2025;46(7):635-645. doi:10.1093/eurheartj/ehae784
  20. Gmeiner JMD, Linnemann M, Steffen J, et al. Dual ProGlide versus ProGlide and FemoSeal for vascular access haemostasis after transcatheter aortic valve implantation. EuroIntervention. 2022;18(10): 812-819. doi:10.4244/EIJ-D-22-00311
  21. Ko TY, Kao HL, Liu YJ, et al. Intentional combination of ProGlide and Angio-Seal for femoral access haemostasis in transcatheter aortic valve replacement. Int J Cardiol. 2019;293:76-79. doi:10.1016/j.ijcard.2019.05.055
  22. Kodama A, Yamamoto M, Shimura T, et al. Comparative data of single versus double proglide vascular preclose technique after percutaneous transfemoral transcatheter aortic valve implantation from the optimized catheter valvular intervention (OCEAN-TAVI) Japanese multicenter registry. Catheter Cardiovasc Interv. 2017;90(3):E55-E62. doi:10.1002/ccd.26686
  23. Iacovelli F, Burattini O, Sturda F, et al. Single suture-mediated closure system after transfemoral transcatheter aortic valve implantation: a single-center real-world experience. Catheter Cardiovasc Interv. 2024; 103(7):1125-1137. doi:10.1002/ccd.31054
  24. Rosseel L, Montarello NJ, Nuyens P, et al. A systematic algorithm for large-bore arterial access closure after TAVI: the TAVI-MultiCLOSE study. EuroIntervention. 2024;20(6):e354. doi:10.4244/eij-d-23-00725
  25. Upadhaya S, Upreti A, Gupta K, et al. Vascular closure devices for large bore femoral access after transfemoral transcatheter aortic valve replacement: a network meta-analysis. Catheter Cardiovasc Interv. 2025; 106(1):423-432. doi:10.1002/ccd.31565